Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The Canadian Journal of Cardiology|January 30, 2015
Adaptation and remodelling of the pulmonary circulation in pulmonary hypertensionMylène Vaillancourt, Grégoire Ruffenach, Jolyane Meloche, et al.
Respiratory Research|November 19, 2020
Pulmonary hypertension secondary to pulmonary fibrosis: clinical data, histopathology and molecular insightsGrégoire Ruffenach, Jason Hong, Mylène Vaillancourt, et al.
Circulation|August 22, 2022
HNRNPA2B1: RNA-Binding Protein That Orchestrates Smooth Muscle Cell Phenotype in Pulmonary Arterial HypertensionGrégoire Ruffenach, Lejla Medzikovic, Laila Aryan, et al.
Cells|December 22, 2023
Functions of RNA-Binding Proteins in Cardiovascular DiseaseGrégoire Ruffenach, Lejla Medzikovic, Wasila Sun, et al.
Pulmonary Circulation|September 30, 2016
Role of oxidized lipids in pulmonary arterial hypertensionSalil Sharma, Grégoire Ruffenach, Soban Umar, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|September 17, 2025
SOX17 in pulmonary arterial hypertension: from development to clinical phenotypeThomas Lacoste-Palasset, Benoit Aguado, Julien Grynblat, et al.
ERJ Open Research|June 3, 2026
Exploring the therapeutic potential of GLP-1 receptor agonists in pulmonary arterial hypertensionBenoit Aguado, Thomas Lacoste-Palasset, Grégoire Ruffenach, et al.
Respiratory Research|November 28, 2024
Intestinal IFNα4 promotes 15-HETE diet-induced pulmonary hypertensionGrégoire Ruffenach, Lejla Medzikovic, Laila Aryan, et al.
JCI Insight|May 8, 2023
Myocardial fibrosis and calcification are attenuated by microRNA-129-5p targeting Asporin and Sox9 in cardiac fibroblastsLejla Medzikovic, Laila Aryan, Grégoire Ruffenach, et al.
Circulation. Heart Failure|December 5, 2025
Use of SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors in Pulmonary HypertensionBenoit Aguado, Grégoire Ruffenach, Thomas Lacoste-Palasset, et al.
Pageof 2